Acemetacin Impurities

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Acemetacin Acemetacin EP Impurity C VL5090008View
Acemetacin Acemetacin EP Impurity D VL5090009View CAS 76812-64-1
Acemetacin Acemetacin EP Impurity E VL5090010View CAS 75302-98-6
Acemetacin Acemetacin EP Impurity F VL5090011View CAS 76812-49-2
Acemetacin Acemetacin Impurity 1 VE0011731View
Acemetacin Acemetacin Impurity 2 VL5090013View
Acemetacin Acemetacin Impurity 4 VL5090003View
Acemetacin Acemetacin Impurity 5 VL5090004View
Acemetacin Acemetacin Impurity 6 VL5090005View
Acemetacin Acemetacin Impurity 7 VE0011728View
Acemetacin Acemetacin-Acyl-β-D-Glucuronide VL5090001View CAS 1260603-31-3
Acemetacin Acemetacin-D4 DVE00110View

Request a quote

1260603-31-3: Acemetacin-Acyl-β-D-Glucuronide

1260603-31-3: Acemetacin-Acyl-β-D-Glucuronide
Catalogue No.

VL5090001
CAS No.

1260603-31-3
Molecular Formula

C27H26ClNO12
Molecular Weight

591.96
Parent drug

Acemetacin
IUPAC Name

2-oxo-2-(((2S, 3R, 5R)-3, 4, 5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)ethyl 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate compound with methanedione (1:1)
Synonyms

N/A
References

Szewczyk, Milena, et al. “Design, Synthesis, and Molecular Docking of New 5-HT Reuptake Inhibitors Based on Modified 1, 2-Dihydrocyclopenta[B]Indol-3(4H)-One Scaffold.” Journal of Chemical Sciences, vol. 131, no. 6, May 2019, https://doi.org/10.1007/s12039-019-1621-x.
Status

Under Development
ListName

Acemetacin-Acyl-β-D-Glucuronide
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url